Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
Journal of Biological Sciences
  Year: 2013 | Volume: 13 | Issue: 8 | Page No.: 727-731
DOI: 10.3923/jbs.2013.727.731
Studying the Treatment Effects of Erythromycin in Patients Suffering from Pityriasis Rosea
Hamideh Azimi, Effat Khodaeiani and Mohamad Goldust

Abstract:
This study aimed at evaluating the efficacy of oral erythromycin in patients with Pityriasis Rosea. Fifty patients were selected which were the divided into 2 groups. In group A (test group) the patients were treated by erythromycin while in group B (plecebo group) the patients received chlorpheniramin or diphenhydramin. Complete response was observed in 16 patients (64%) in the treatment group (A) and none in the second group (B) (p = 0/0001). It is recommended to treat the patients suffering from pityriasis rosea at any time of disease diagnosis using oral erythromycin for a two-week period.
 [Fulltext PDF]   [Fulltext HTML]   [XML: Abstract + References]   [References]   [View Citation]  [Report Citation]
 RELATED ARTICLES:
  •    IgG Antibodies in Patients with Pemphigus Vulgaris before and after Diagnosing with Immunofluorescence
  •    Evaluation of Magnetic Resonance Imaging Signal Changes in Vertebral Depressed Fractures to Determine the Fracture Time
  •    Complications in Premature Labor Between Severe Preeclampsia and Normal Pregnancies
  •    Serum Iron and Ferritin Level in Idiopathic Parkinson
How to cite this article:

Hamideh Azimi, Effat Khodaeiani and Mohamad Goldust, 2013. Studying the Treatment Effects of Erythromycin in Patients Suffering from Pityriasis Rosea. Journal of Biological Sciences, 13: 727-731.

DOI: 10.3923/jbs.2013.727.731

URL: https://scialert.net/abstract/?doi=jbs.2013.727.731

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 

Curve Bottom